Temporal expression of cyclooxygenase-2 in peritoneal macrophages of rats and effects of panax notoginseng saponins

Inflammation Research

Volumn 58, Issue 2, 2009, Pages 74-80

  Yuan, Z B ^a   Zhang, H G ^a   Jia, Y ^a   Cheng, Y Q ^a   Li, X H ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cyclooxygenase 2; Inflammation; Macrophage; Panax notoginseng saponins; Phagocytosis

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; PROSTAGLANDIN D2; PROSTAGLANDIN E2; SAPONIN DERIVATIVE; ZYMOSAN;

ANIMAL EXPERIMENT; ARTICLE; CHICKEN; CONTROLLED STUDY; DRUG MECHANISM; ERYTHROCYTE; MALE; NONHUMAN; PANAX NOTOGINSENG; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CHICKENS; CYCLOOXYGENASE 2; DINOPROSTONE; MACROPHAGES, PERITONEAL; MALE; PANAX NOTOGINSENG; PROSTAGLANDIN D2; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SAPONINS; ZYMOSAN;

EID: 59049092159     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-8044-y     Document Type: Article

References (50)

1. Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res 2003; 110: 255-8.
2. Ishihara S, Rumi MA, Okuyama T, Kinoshita Y. Effect of prostaglandins on the regulation of tumor growth. Curr Med Chem Anticancer Agents 2004; l4: 379-87.
3. Elvevoll EO, Osterud B. Impact of processing on nutritional quality of marine food items. Forum Nutr 2003; 56: 337-40.
4. Liang X, Wu L, Wang Q, Hand T, Bilak M, McCullough L, et al. Function of COX-2 and Prostaglandins in Neurological Disease. J Mol Neurosci 2007; 33: 94-9.
5. Sharma RA, Gescher A, Plastaras JP, Leuratti C, Singh R, Gallacher-Horley B, et al. Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells. Carcinogenesis 2001; 22: 1557-60.
6. Turini ME, DuBois RN. Cyclooxygenase-2: a therapeutic target. Annu Rev Med 2002; 53: 35-57.
7. Wu MH, Sun HS, Lin CC, Hsiao KY, Chuang PC, Pan HA, et al. Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis. Mol Hum Reprod 2002; 8: 1103-10.
8. Giroux M, Descoteaux A. Cyclooxygenase-2 expression in macrophages: modulation by protein kinase C-alpha. J Immunol. 2000; 165: 3985-91.
9. Wu MH, Shoji Y, Chuang PC, Tsai SJ. Endometriosis: disease pathophysiology and the role of prostaglandins. Expert Rev Mol Med 2007; 9: 1-20.
10. Yang ZG, Sun HX, Ye YP. Ginsenoside Rd from Panax notoginseng is cytotoxic towards HeLa cancer cells and induces apoptosis. Chem Biodivers 2006; 3: 187-97.
11. Li SH, Chu Y. Anti-inflammatory effects of total saponins of Panax notoginseng. Acta Pharmacol Sin 1999; 20: 551-4.
12. Sun K, Wang CS, Guo J, Liu YY, Wang F, Liu LY, et al. Effect of Panax notoginseng saponins on lipopolysaccharide-induced adhesion of leukocytes in rat mesenteric venules. Clin Hemorheol Microcirc 2006; 34: 103-8.
13. Rhule A, Navarro S, Smith JR, Shepherd DM. Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cells. J Ethnopharmacol 2006; 106: 121-8.
14. 2. Prostaglandins 1985; 30: 769-89.
15. Tang C, Xue YR, Yu F, Liu CH. Establishment of a new method to determine macrophagic phagocytosis activity for CRBC. Anim Husbandry Vet Med 2005; 37: 47-49.
16. Huang J, Qin HL, Huang XK, Zhou JH. Effect of CRH on phagocytosis of rat enterocoelia macrophage. J Trauma Surh 2006; 8: 59-62.
17. Carvalho MDT, Tobias VE, Vendrame MV, Shimabukuro AFM, Gidlund M, Quintão ECR. Zymosan phagocytosis by mouse peritoneal macrophages is increased by apoHDL- and not by intact HDL-covered particles. Braz J Med Biol Res. 2000; 33: 313-6.
18. van der Ploeg JR, Giertsen E, Lüdin B, Mörgeli C, Zinkernagel AS, Gmür R. Quantitative detection of Porphyromonas gingivalis fimA genotypes in dental plaque. FEMS Microbiol Lett 2004; 232: 31-7.
19. Ceckova M, Libra A, Pavek P, Nachtigal P, Brabec M, Fuchs R, et al. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo. Clin Exp Pharmacol Physiol 2006; 33: 58-65.
20. Liu XJ, Luo FM, Pan KJ, Wu WC, Chen HQ. High glucose upregulates connective tissue growth factor expression in human vascular smooth muscle cells. BMC Cell Biol 2007; 8: 1-16.
21. Eliopoulos AG, Dumitru CD, Wang CC, Cho J, Tsichlis PN. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J 2002; 21: 4831-40.
22. 2 in lipopolysaccharide- stimulated rat peritoneal macrophages. Biochem Biophys Res Commun 1997; 230: 110-4.
23. 2 expression by interleukin-1beta in cultured primary human amnion fibroblasts. Placenta. 2006; 27: 164-70.
24. Stout RD, Suttles J. Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes. Immunol Rev 2005; 205: 60-71.
25. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
26. Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004; 76: 509-513.
27. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, et al. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 1995; 80: 353-61.
28. Vásquez-Garibay E, Campollo-Rivas O, Romero-Velarde E, Méndez-Estrada C, García-Iglesias T, Alvizo-Mora JG, et al. Effect of Renutrition on Natural and Cell-Mediated Immune Response in Infants With Severe Malnutrition. J Pediatr Gastroenterol Nutr 2002; 34: 296-301.
29. Magae J, Nagi T, Takaku K, Kataoka T, Koshino H, Uramoto M, et al. Screening for specific inhibitors of phagocytosis of thioglycollate-elicited macrophages. Biosci Biotechnol Biochem 1994; 58: 104-7.
30. Aderem A. Phagocytosis and the inflammatory response. J Infect Dis 2003; 187(suppl 2): S340-5.
31. Lee DJ, Cox D, Li J, Greenberg S. Rac1 and Cdc42 are required for phagocytosis, but not NF-kappaB-dependent gene expression, in macrophages challenged with Pseudomonas aeruginosa. J Biol Chem. 2000; 275: 141-6.
32. Aronoff DM, Canetti C, Peters-Golden M. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J Immunol. 2004; 173: 559-65.
33. Davidson J, Kerr A, Guy K, Rotondo D. Prostaglandin and fatty acid modulation of Escherichia coli O157 phagocytosis by human monocytic cells. Immunology. 1998; 94: 228-34.
34. Rouzer CA, Tranguch S, Wang H, Zhang H, Dey SK, Marnett LJ. Zymosan-induced glycerylprostaglandin and prostaglandin synthesis in resident peritoneal macrophages: roles of cyclo-oxygenase-1 and -2. Biochem J 2006; 399: 91-9.
35. Kolaczkowska E, Shahzidi S, Seljelid R, van Rooijen N, Plytycz B. Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. Inflammation 2002; 26: 61-71.
36. Canning BJ, Hmieleski RR, Spannhake EW, Jakab GJ. Ozone reduces murine alveolar and peritoneal macrophage phagocytosis: the role of prostanoids. Am J Physiol 1991; 261: L277-82.
37. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 1999; 5: 698-701.
38. Paumelle R, Staels B. Peroxisome proliferator-activated receptors mediate pleiotropic actions of statins. Circ Res 2007; 100: 1394-5.
39. Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, Taketa K, et al. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. Circ Res 2007; 100: 1442-51.
40. 2 in macrophages. J Biol Chem 2007; 282: 17964-73.
41. Kanunfre CC, da-Silva-Freitas JJ, Pompeia C, Goncalves-de-Almeida DC, Cury-Boaventura MF; Verlengia R, et al. Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells. Int Immunopharmacol 2004; 4: 1171-85.
42. Lee KH. Research and future trends in the pharmaceutical development of medicinal herbs from Chinese medicine. Public Health Nutr 2000; 3: 515-22.
43. Zhu Y, Pettolino F, Mau SL, Shen YC, Chen CF, Kuo YC, et al. Immunoactive polysaccharide-rich fractions from Panax notoginseng. Planta Med 2006; 72: 1193-9.
44. Yao RB, Guo JH, Hu B, Cai H. Clinical study of panax notoginseng saponins for improving symptom of rheumatoid arthritis and correlative indexes. J Yunnan Coll Tradit Chin Med 2006; 29(5): 32-34. Chinese.
45. Ma WG, Mizutania M, Malterud KE. Saponins from the roots of Panax notoginseng. Phytochemistry 1999; 52: 1133-9.
46. Rajput ZI, Hu SH, Xiao CW, Arijo AG. Adjuvant effects of saponins on animal immune responses. J Zhejiang Univ Sci B. 2007; 8: 153-61. Chinese
47. Sun H, Ye Y, Pan Y. Immunological-adjuvant saponins from the roots of Panax notoginseng. Chem Biodivers 2005; 2: 510-5.
48. Rajakariar R, Yaqoob MM, Gilroy DW. COX-2 in inflammation and resolution. Mol Interv 2006; 6: 199-207.
49. 2 produced by inducible cyclooxygenase may contribute to the resolution of inflammation. Inflammopharmacology 2005; 12: 473-6.
50. 2 in murine macrophages. Int Immunopharmacol. 2007; 7: 1450-9.